Abstract
Autism is characterized as one of the pervasive developmental disorders, a spectrum of often severe behavioral and cognitive disturbances of early development. The high heritability of autism has driven multiple efforts to identify genetic variation that increases autism susceptibility. Numerous studies have suggested that variation in peripheral and central metabolism of serotonin (5-hydroxytryptamine) may play a role in the pathophysiology of autism. We screened 403 autism families for 45 single nucleotide polymorphisms in ten serotonin pathway candidate genes. Although genome-wide linkage scans in autism have provided support for linkage to various loci located within the serotonin pathway, our study does not provide strong evidence for linkage to any specific gene within the pathway. The most significant association (p = 0.0002; p = 0.02 after correcting for multiple comparisons) was found at rs1150220 (HTR3A) located on chromosome 11 (∼113 Mb). To test specifically for multilocus effects, multifactor dimensionality reduction was employed, and a significant two-way interaction (p value = 0.01) was found between rs10830962, near MTNR1B (chromosome11; 92,338,075 bp), and rs1007631, near SLC7A5 (chromosome16; 86,413,596 bp). These data suggest that variation within genes on the serotonin pathway, particularly HTR3A, may have modest effects on autism risk.
Similar content being viewed by others
References
Fombonne E (1999) The epidemiology of autism: a review. Psychol Med 29:769–786. doi:10.1017/S0033291799008508
Williams JG, Higgins JP, Brayne CE (2006) Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child 91:8–15. doi:10.1136/adc.2004.062083
Fombonne E (2003) Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 33:365–382. doi:10.1023/A:1025054610557
Veenstra-Vanderweele J, Christian SL, Cook EH Jr (2004) Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 5:379–405. doi:10.1146/annurev.genom.5.061903.180050
Veenstra-Vanderweele J, Cook EH Jr (2004) Molecular genetics of autism spectrum disorder. Mol Psychiatry 9:819–832. doi:10.1038/sj.mp.4001505
Folstein S, Rutter M (1977) Genetic influences and infantile autism. Nature 265:726–728. doi:10.1038/265726a0
Rutter M, Macdonald H, Le CA, Harrington R, Bolton P, Bailey A (1990) Genetic factors in child psychiatric disorders—II. Empirical findings. J Child Psychol Psychiatry 31:39–83. doi:10.1111/j.1469-7610.1990.tb02273.x
Rutter M, Bolton P, Harrington R, Le CA, Macdonald H, Simonoff E (1990) Genetic factors in child psychiatric disorders—I. A review of research strategies. J Child Psychol Psychiatry 31:3–37. doi:10.1111/j.1469-7610.1990.tb02272.x
Piven J (2001) The broad autism phenotype: a complementary strategy for molecular genetic studies of autism. Am J Med Genet 105:34–35. doi:10.1002/1096-8628(20010108)105:1<34::AID-AJMG1052>3.0.CO;2-D
Pickles A, Bolton P, Macdonald H, Bailey A, Le CA, Sim CH, Rutter M (1995) Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet 57:717–726
Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL, Childress D, Folstein SE, Garcia M, Gardiner MB, Gilman S, Haines JL, Hopkins K, Landa R, Meyer NH, Mullane JA, Nishimura DY, Palmer P, Piven J, Purdy J, Santangelo SL, Searby C, Sheffield V, Singleton J, Slager S (1999) An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet 88:609–615. doi:10.1002/(SICI)1096-8628(19991215)88:6<609::AID-AJMG7>3.0.CO;2-L
Buxbaum JD, Silverman JM, Smith CJ, Kilifarski M, Reichert J, Hollander E, Lawlor BA, Fitzgerald M, Greenberg DA, Davis KL (2001) Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet 68:1514–1520. doi:10.1086/320588
International Molecular Genetic Study Autism Consortium (IMGSAC) (2001) A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 69:570–581. doi:10.1086/323264
Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, Lord C, Iversen P, Hoh J, Ott J, Gilliam TC (2001) A genomewide screen for autism susceptibility loci. Am J Hum Genet 69:327–340. doi:10.1086/321980
Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Van ML, Penet C, Feingold J, Brice A, Leboyer M (1999) Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 8:805–812. doi:10.1093/hmg/8.5.805
Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Petersen PB, Pingree C, McMahon W, Wong DL, Cavalli-Sforza LL, Kraemer HC, Myers RM (1999) A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 65:493–507. doi:10.1086/302497
Shao Y, Wolpert CM, Raiford KL, Menold MM, Donnelly SL, Ravan SA, Bass MP, McClain C, von WL, Vance JM, Abramson RH, Wright HH, shley-Koch A, Gilbert JR, DeLong RG, Cuccaro ML, Pericak-Vance MA (2002) Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet 114:99–105. doi:10.1002/ajmg.10153
Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C, Bryson SE, Jones MB, Marshall CR, Scherer SW, Vieland VJ, Bartlett C, Mangin LV, Goedken R, Segre A, Pericak-Vance MA, Cuccaro ML, Gilbert JR, Wright HH, Abramson RK, Betancur C, Bourgeron T, Gillberg C, Leboyer M, Buxbaum JD, Davis KL, Hollander E, Silverman JM, Hallmayer J, Lotspeich L, Sutcliffe JS, Haines JL, Folstein SE, Piven J, Wassink TH, Sheffield V, Geschwind DH, Bucan M, Brown WT, Cantor RM, Constantino JN, Gilliam TC, Herbert M, Lajonchere C, Ledbetter DH, Lese-Martin C, Miller J, Nelson S, Samango-Sprouse CA, Spence S, State M, Tanzi RE, Coon H, Dawson G, Devlin B, Estes A, Flodman P, Klei L, McMahon WM, Minshew N, Munson J, Korvatska E, Rodier PM, Schellenberg GD, Smith M, Spence MA, Stodgell C, Tepper PG, Wijsman EM, Yu CE, Roge B, Mantoulan C, Wittemeyer K, Poustka A, Felder B, Klauck SM, Schuster C, Poustka F, Bolte S, Feineis-Matthews S, Herbrecht E, Schmotzer G, Tsiantis J, Papanikolaou K, Maestrini E, Bacchelli E, Blasi F, Carone S, Toma C, Van EH, de JM, Kemner C, Koop F, Langemeijer M, Hijimans C, Staal WG, Baird G, Bolton PF, Rutter ML, Weisblatt E, Green J, Aldred C, Wilkinson JA, Pickles A, Le CA, Berney T, McConachie H, Bailey AJ, Francis K, Honeyman G, Hutchinson A, Parr JR, Wallace S, Monaco AP, Barnby G, Kobayashi K, Lamb JA, Sousa I, Sykes N, Cook EH, Guter SJ, Leventhal BL, Salt J, Lord C, Corsello C, Hus V, Weeks DE, Volkmar F, Tauber M, Fombonne E, Shih A (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319–328. doi:10.1038/ng1985
Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, Rea A, Guy M, Lin S, Cook EH, Chakravarti A (2008) A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 82:160–164. doi:10.1016/j.ajhg.2007.09.015
Nyholt DR (2001) Genetic case–control association studies—correcting for multiple testing. Hum Genet 109:564–567. doi:10.1007/s00439-001-0611-4
Stone JL, Merriman B, Cantor RM, Yonan AL, Gilliam TC, Geschwind DH, Nelson SF (2004) Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet 75:1117–1123. doi:10.1086/426034
Cantor RM, Kono N, Duvall JA, varez-Retuerto A, Stone JL, Alarcon M, Nelson SF, Geschwind DH (2005) Replication of autism linkage: fine-mapping peak at 17q21. Am J Hum Genet 76:1050–1056. doi:10.1086/430278
Schain RJ, Freedman DX (1961) Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 58:315–320. doi:10.1016/S0022-3476(61)80261-8
Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S (2002) Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 7:831–836. doi:10.1038/sj.mp.4001099
Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8:348–354. doi:10.1097/00008480-199608000-00008
Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28:885–900. doi:10.1111/j.1469-7610.1987.tb00677.x
Cook EH Jr, Leventhal BL, Freedman DX (1988) Free serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry 24:488–491. doi:10.1016/0006-3223(88)90192-8
McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:993–1000
Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45:287–295. doi:10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9
Cook EH Jr, Leventhal BL, Freedman DX (1988) Serotonin and measured intelligence. J Autism Dev Disord 18:553–559. doi:10.1007/BF02211873
Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R (2005) A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30:582–589. doi:10.1038/sj.npp.1300627
Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E (2006) Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol 9:209–213. doi:10.1017/S1461145705005791
Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD (2005) Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci U S A 102:11545–11550. doi:10.1073/pnas.0501432102
Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77:265–279. doi:10.1086/432648
McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD, Folstein SE, Haines JL, Sutcliffe JS (2004) Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet B Neuropsychiatr Genet 127:104–112. doi:10.1002/ajmg.b.20151
Ramoz N, Reichert JG, Corwin TE, Smith CJ, Silverman JM, Hollander E, Buxbaum JD (2006) Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol Psychiatry 60:186–191. doi:10.1016/j.biopsych.2006.01.009
Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH Jr, Scott BL, Goetz CG, Small GW, Mastaglia FL, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER (2003) Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol 60:975–980. doi:10.1001/archneur.60.7.975
O’Connell JR, Weeks DE (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259–266. doi:10.1086/301904
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265. doi:10.1093/bioinformatics/bth457
Ott J (1999) Analysis of human genetic linkage, 3rd edn. Johns Hopkins University Press, Baltimore
Hodge SE (1994) What association analysis can and cannot tell us about the genetics of complex disease. Am J Med Genet 54:318–323. doi:10.1002/ajmg.1320540408
Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER (2003) Genotype-based association test for general pedigrees: the genotype-PDT. Genet Epidemiol 25:203–213. doi:10.1002/gepi.10258
Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765–769. doi:10.1086/383251
Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138–147. doi:10.1086/321276
Ma DQ, Whitehead PL, Menold MM, Martin ER, shley-Koch AE, Mei H, Ritchie MD, DeLong GR, Abramson RK, Wright HH, Cuccaro ML, Hussman JP, Gilbert JR, Pericak-Vance MA (2005) Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 77:377–388. doi:10.1086/433195
Ritchie MD, Edwards TL, Fanelli TJ, Motsinger AA (2007) Genetic heterogeneity is not as threatening as you might think. Genet Epidemiol 31:797–800. doi:10.1002/gepi.20256
Reeves DC, Lummis SC (2002) The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel. Mol Membr Biol 19:11–26 reviewdoi:10.1080/09687680110110048
Jackson MB, Yakel JL (1995) The 5-HT3 receptor channel. Annu Rev Physiol 57:447–468. doi:10.1146/annurev.ph.57.030195.002311
Krzywkowski K (2006) Do polymorphisms in the human 5-HT3 genes contribute to pathological phenotypes? Biochem Soc Trans 34:872–876. doi:10.1042/BST0340872
Bruss M, Eucker T, Gothert M, Bonisch H (2000) Exon–intron organization of the human 5-HT3A receptor gene. Neuropharmacology 39:308–315. doi:10.1016/S0028-3908(99)00116-1
Niesler B, Frank B, Kapeller J, Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101–111. doi:10.1016/S0378-1119(03)00503-1
Morales M, Wang SD (2002) Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci 22:6732–6741
Alessandro S, Kato M (2008) The serotonin transporter gene and effectiveness of SSRIs. Expert Rev Neurother 8:111–120. doi:10.1586/14737175.8.1.111
Merens W, Willem Van der Does AJ, Spinhoven P (2007) The effects of serotonin manipulations on emotional information processing and mood. J Affect Disord 103:43–62. doi:10.1016/j.jad.2007.01.032
Sanger DJ, Soubrane C, Scatton B (2007) New perspectives for the treatment of disorders of sleep and arousal. Ann Pharm Fr 65:268–274. doi:10.1016/S0003-4509(07)90046-2
Steffen KJ, Roerig JL, Mitchell JE, Uppala S (2006) Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs 11:315–336. doi:10.1517/14728214.11.2.315
Niesler B, Weiss B, Fischer C, Nothen MM, Propping P, Bondy B, Rietschel M, Maier W, Albus M, Franzek E, Rappold GA (2001) Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 11:21–27. doi:10.1097/00008571-200102000-00003
Niesler B, Kapeller J, Hammer C, Rappold G (2008) Serotonin type 3 receptor genes: HTR3A, B, C, D, E. Pharmacogenomics 9:501–504. doi:10.2217/14622416.9.5.501
Melke J, Westberg L, Nilsson S, Landen M, Soderstrom H, Baghaei F, Rosmond R, Holm G, Bjorntorp P, Nilsson LG, Adolfsson R, Eriksson E (2003) A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry 60:1017–1023. doi:10.1001/archpsyc.60.10.1017
Ji X, Takahashi N, Saito S, Ishihara R, Maeno N, Inada T, Ozaki N (2008) Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population. Neurosci Lett 435:95–98. doi:10.1016/j.neulet.2008.01.083
Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Takao H, Minabe Y, Nakatani N, Higuchi T, tera-Wadleigh SD, Yoshikawa T (2006) Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry 60:192–201. doi:10.1016/j.biopsych.2005.11.008
Krzywkowski K, Jensen AA, Connolly CN, Brauner-Osborne H (2007) Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression. Pharmacogenet Genomics 17:255–266
Acknowledgments
We wish to thank both the patients with autism and their family members who agreed to participate in this study, as well as the personnel of the Center for Human Genetics Research at Vanderbilt University and the Miami Institute for Human Genomics at the University of Miami. We would like to thank M.J. Allen for her excellent technical support. This research was supported in part by National Institutes of Health (NIH) program project grant NS026630 (MPV, JLH) and NIH R01 grant MH080647.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 285 KB)
Rights and permissions
About this article
Cite this article
Anderson, B.M., Schnetz-Boutaud, N.C., Bartlett, J. et al. Examination of association of genes in the serotonin system to autism. Neurogenetics 10, 209–216 (2009). https://doi.org/10.1007/s10048-009-0171-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-009-0171-7